BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30255803)

  • 1. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
    Prodduturi N; Bhagwate A; Kocher JA; Sun Z
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indel detection from RNA-seq data: tool evaluation and strategies for accurate detection of actionable mutations.
    Sun Z; Bhagwate A; Prodduturi N; Yang P; Kocher JA
    Brief Bioinform; 2017 Nov; 18(6):973-983. PubMed ID: 27473065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
    Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.
    Paul MR; Levitt NP; Moore DE; Watson PM; Wilson RC; Denlinger CE; Watson DK; Anderson PE
    BMC Genomics; 2016 Mar; 17():263. PubMed ID: 27029813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay.
    Guseva NV; Jaber O; Stence AA; Sompallae K; Bashir A; Sompallae R; Bossler AD; Jensen CS; Ma D
    Cancer Cytopathol; 2018 Mar; 126(3):158-169. PubMed ID: 29364576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SimBA: A methodology and tools for evaluating the performance of RNA-Seq bioinformatic pipelines.
    Audoux J; Salson M; Grosset CF; Beaumeunier S; Holder JM; Commes T; Philippe N
    BMC Bioinformatics; 2017 Sep; 18(1):428. PubMed ID: 28969586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
    Liu Y; Loewer M; Aluru S; Schmidt B
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
    Atak ZK; Gianfelici V; Hulselmans G; De Keersmaecker K; Devasia AG; Geerdens E; Mentens N; Chiaretti S; Durinck K; Uyttebroeck A; Vandenberghe P; Wlodarska I; Cloos J; Foà R; Speleman F; Cools J; Aerts S
    PLoS Genet; 2013; 9(12):e1003997. PubMed ID: 24367274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
    Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
    Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance assessment of variant calling pipelines using human whole exome sequencing and simulated data.
    Kumaran M; Subramanian U; Devarajan B
    BMC Bioinformatics; 2019 Jun; 20(1):342. PubMed ID: 31208315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified Reaction.
    Song Z; Xu C; He Y; Li F; Wang W; Zhu Y; Gao Y; Ji M; Chen M; Lai J; Cheng W; Benes CH; Chen L
    Clin Chem; 2020 Jan; 66(1):178-187. PubMed ID: 31810998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly developed capture-based sequencing panel for genomic assay of lung cancer.
    Im SW; Chae J; Jang SS; Choi J; Yun J; Cha S; Kwon NJ; Jeon YK; Hwang Y; Kim M; Kim TM; Kim DW; Kim JI; Kim YT
    Genes Genomics; 2020 Jul; 42(7):751-759. PubMed ID: 32449066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
    Lindquist KE; Karlsson A; Levéen P; Brunnström H; Reuterswärd C; Holm K; Jönsson M; Annersten K; Rosengren F; Jirström K; Kosieradzki J; Ek L; Borg Å; Planck M; Jönsson G; Staaf J
    Oncotarget; 2017 May; 8(21):34796-34810. PubMed ID: 28415793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using high-throughput sequencing transcriptome data for INDEL detection: challenges for cancer drug discovery.
    Wajnberg G; Passetti F
    Expert Opin Drug Discov; 2016; 11(3):257-68. PubMed ID: 26787005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
    Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J
    Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference.
    Cornish A; Guda C
    Biomed Res Int; 2015; 2015():456479. PubMed ID: 26539496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.